Viewing Study NCT01661868

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2026-02-23 @ 12:21 PM
Study NCT ID: NCT01661868
Status: WITHDRAWN
Last Update Posted: 2012-08-21
First Post: 2011-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer
Sponsor: Dana-Farber Cancer Institute
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Peritoneal Cancer View
None Fallopian Tube Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRCA1 mutation View
None BRCA2 mutation View